Royal Sense [ROYAL] vs Entero Healthcare [ENTERO] Detailed Stock Comparison

Royal Sense

BSE
Loading...

Entero Healthcare

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Royal Sense wins in 11 metrics, Entero Healthcare wins in 6 metrics, with 0 ties. Royal Sense appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRoyal SenseEntero HealthcareBetter
P/E Ratio (TTM)20.9648.24Royal Sense
Price-to-Book Ratio4.442.86Entero Healthcare
Debt-to-Equity Ratio11.7421.76Royal Sense
PEG RatioN/A1.26N/A
EV/EBITDA12.9725.34Royal Sense
Profit Margin (TTM)10.26%1.90%Royal Sense
Operating Margin (TTM)12.41%2.94%Royal Sense
EBITDA Margin (TTM)12.41%2.94%Royal Sense
Return on Equity27.55%5.36%Royal Sense
Return on Assets (TTM)19.68%3.51%Royal Sense
Free Cash Flow (TTM)$-4.08M$-881.80MRoyal Sense
1-Year Return19.78%-13.53%Royal Sense
Price-to-Sales Ratio (TTM)2.150.91Entero Healthcare
Enterprise Value$1.15B$49.37BEntero Healthcare
EV/Revenue Ratio1.870.91Entero Healthcare
Gross Profit Margin (TTM)15.60%9.94%Royal Sense
Revenue per Share (TTM)$124$1,242Entero Healthcare
Earnings per Share (Diluted)$11.83$23.51Entero Healthcare
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Royal Sense vs Entero Healthcare Stock Performance Analysis

Loading Price Chart...

Royal Sense
Entero Healthcare
Royal Sense Stock Overview | Entero Healthcare Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Royal Sense-1.25%-5.81%-8.99%2.30%36.06%-19.97%
Entero Healthcare-0.40%3.19%-3.55%-5.33%0.08%-21.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Royal Sense19.78%119.70%119.70%119.70%119.70%119.70%
Entero Healthcare-13.53%-1.92%-1.92%-1.92%-1.92%-1.92%

News Based Sentiment: Royal Sense vs Entero Healthcare

Royal Sense

News based Sentiment: MIXED

Royal Sense Ltd. has shown strong financial growth, with a significant increase in net profit and market capitalization. However, the recent stock price decline and changes in shareholding patterns introduce uncertainty and suggest a potential shift in investor sentiment, creating a mixed investment outlook.

View Royal Sense News Sentiment Analysis

Entero Healthcare

News based Sentiment: MIXED

October presented a mixed bag for Entero Healthcare Solutions, with positive price movements and analyst upgrades offset by continued volatility, a 52-week low, and a recent divestiture. The company is clearly in a period of change, making this a significant month for investors to assess its future direction.

View Entero Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: Royal Sense vs Entero Healthcare

MetricROYALENTERO
Market Information
Market Cap i₹1.38B₹49.35B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,500197,998
90 Day Avg. Volume i4,883136,874
Last Close₹244.90₹1,123.00
52 Week Range₹175.00 - ₹316.05₹1,044.90 - ₹1,584.25
% from 52W High-22.51%-29.11%
All-Time High₹316.05 (Dec 30, 2024)₹1,584.25 (Nov 04, 2024)
% from All-Time High-22.51%-29.11%
Growth Metrics
Quarterly Revenue Growth4.19%0.28%
Quarterly Earnings Growth3.97%0.38%
Financial Health
Profit Margin (TTM) i0.10%0.02%
Operating Margin (TTM) i0.12%0.03%
Return on Equity (TTM) i0.28%0.05%
Debt to Equity (MRQ) i11.7421.76
Cash & Liquidity
Book Value per Share (MRQ)₹55.83₹396.70
Cash per Share (MRQ)₹22.64₹73.09
Operating Cash Flow (TTM) i₹12.08M₹-1,784,990,000
Levered Free Cash Flow (TTM) i₹-32,759,124₹948.20M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Royal Sense vs Entero Healthcare

MetricROYALENTERO
Price Ratios
P/E Ratio (TTM) i20.9648.24
Forward P/E iN/A22.17
PEG Ratio iN/A1.26
Price to Sales (TTM) i2.150.91
Price to Book (MRQ) i4.442.86
Market Capitalization
Market Capitalization i₹1.38B₹49.35B
Enterprise Value i₹1.15B₹49.37B
Enterprise Value Metrics
Enterprise to Revenue i1.870.91
Enterprise to EBITDA i12.9725.34
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i₹55.83₹396.70

Financial Statements Comparison: Royal Sense vs Entero Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ROYALENTERO
Revenue/Sales i₹33.92M₹14.04B
Cost of Goods Sold i₹28.63M₹12.64B
Gross Profit i₹5.29M₹1.40B
Research & Development iN/AN/A
Operating Income (EBIT) i₹2.60M₹412.02M
EBITDA i₹2.69M₹558.96M
Pre-Tax Income i₹2.65M₹363.63M
Income Tax i₹690,000₹61.31M
Net Income (Profit) i₹1.96M₹302.32M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ROYALENTERO
Cash & Equivalents i₹30.67M₹2.29B
Total Current Assets i₹223.51M₹20.76B
Total Current Liabilities i₹34.38M₹8.45B
Long-Term Debt iN/A₹670.18M
Total Shareholders Equity i₹205.89M₹17.70B
Retained Earnings iN/A₹638.28M
Property, Plant & Equipment iN/A₹1.64B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ROYALENTERO
Operating Cash Flow i₹50.91MN/A
Capital Expenditures i₹233,000N/A
Free Cash Flow i₹26.63MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricROYALENTERO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,500197,998
Average Daily Volume (90 Day) i4,883136,874
Shares Outstanding i4.97M43.51M
Float Shares i1.50M11.24M
% Held by Insiders i0.68%0.63%
% Held by Institutions i0.00%0.20%

Dividend Analysis & Yield Comparison: Royal Sense vs Entero Healthcare

MetricROYALENTERO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A